584688AE5
The Medicines Company
Could not find a ticker for this position, may be a filing error
A biopharmaceutical firm focused on acute and hospital care, known for Angiomax, a blood thinner used during heart procedures, and later inclisiran, a cholesterol-lowering medicine. Founded in 1996 by Dr. Clive Meanwell, the company built its business on "rescuing" drug candidates big pharma had shelved. Its first big drug came from a discontinued Biogen project — a blood thinner inspired by the saliva of medicinal leeches.
CONVERTIBLEUnderlying: MDCOCUSIP: 584688AE5HealthcareUS1 derivative reporter
2.50% Convertible Senior Notes due 2022
No tracked superinvestor held this security as stock in this period — only the derivative positions below reference it.
Derivative Reporters
Investor
Kind
13F reported value
Quantity
Change
